can i use my hsa for glp-1 medication Eligible Medications Are Weight-Loss Programs, Pills &
Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes management as an adjunct to diet and exercise
doi: 10.1016/j.biopsych.2014.10.014 17 BoldriniM.UnderwoodM
Wegovy doses are typically increased every 4 weeks until you reach the maintenance dose of either 2.4mg, 7.2mg per week or 1.7mg per week if you are unable to manage the highest dose
A literature review article published in 2023 summarized the results of three clinical trials (SUSTAIN, PIONEER and STEP) on the weight loss effect of semaglutide
